Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

NCRI 2016: Marker for aggressive prostate cancer doubles as a drug target

NCRI 2016: Marker for aggressive prostate cancer doubles as a drug target

Tailored, dense-dose chemotherapy for early breast cancer does not result in significant improvement

Tailored, dense-dose chemotherapy for early breast cancer does not result in significant improvement

Potential targeted therapy found for newly identified leukaemia subtype with poor outcome

Potential targeted therapy found for newly identified leukaemia subtype with poor outcome

Checkpoint blockade helps only a subset of patients, why?

Checkpoint blockade helps only a subset of patients, why?

Scientists discover a cause of multiple resistance to cancer chemotherapy

Scientists discover a cause of multiple resistance to cancer chemotherapy

Little benefit using G-CSF for chemotherapies with low infection risk

Little benefit using G-CSF for chemotherapies with low infection risk

Study details rare cardiac side effects of immune checkpoint cancer therapies

Study details rare cardiac side effects of immune checkpoint cancer therapies

Epigenetic approach for leukaemia renders cancer genes powerless

Epigenetic approach for leukaemia renders cancer genes powerless

Most breast and cervical cancer deaths occur in developing countries, yet many could be prevented with cost-effective interventions

Most breast and cervical cancer deaths occur in developing countries, yet many could be prevented with cost...

'Junk' DNA may have significant roles in disease progression

'Junk' DNA may have significant roles in disease progression

More from ecancer